Pharmacogenetic effects of regulatory nuclear receptors (PXR, CAR, RXRα and HNF4α) on docetaxel disposition in Chinese nasopharyngeal cancer patients
- 6 November 2013
- journal article
- clinical trial
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 70 (2) , 155-166
Abstract
This exploratory study was aimed at elucidating the pharmacogenetics of regulatory nuclear receptors (PXR, CAR, RXRα and HNF4α) and their implications on docetaxel pharmacokinetics and pharmacodynamics in local Chinese nasopharyngeal cancer patients.Keywords
This publication has 52 references indexed in Scilit:
- In Silico and In Vitro Identification of MicroRNAs That Regulate Hepatic Nuclear Factor 4α ExpressionDrug Metabolism and Disposition, 2012
- Influence of SLCO1B3 haplotype‐tag SNPs on docetaxel disposition in Chinese nasopharyngeal cancer patientsBritish Journal of Clinical Pharmacology, 2011
- Population Pharmacokinetic Modeling of the Association between 63396C→T Pregnane X Receptor Polymorphism and Unboosted Atazanavir ClearanceAntimicrobial Agents and Chemotherapy, 2010
- Genetic variation in the retinoid X receptor and calcium-sensing receptor and risk of colorectal cancer in the Colon Cancer Family RegistryCarcinogenesis, 2010
- Genetic Polymorphisms in Vitamin D Receptor VDR/RXRA Influence the Likelihood of Colon Adenoma RecurrenceCancer Research, 2010
- Analysis of SNPs and Haplotypes in Vitamin D Pathway Genes and Renal Cancer RiskPLOS ONE, 2009
- TAGster: efficient selection of LD tag SNPs in single or multiple populationsBioinformatics, 2007
- PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage AnalysesThe American Journal of Human Genetics, 2007
- A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistanceProceedings of the National Academy of Sciences, 2007
- Haploview: analysis and visualization of LD and haplotype mapsBioinformatics, 2004